Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...

A lower apixaban dose is indicated in patients with an eGFR less than 30 mL/min/1.73 m2, regardless of dialysis status.

Perspective from Geoffrey Barnes, MD, MSc CHICAGO — For patients with cancer requiring extended anticoagulant therapy, a strategy of reduced-dose apixaban was noninferior to full-dose apixaban ...

Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...

"The only dose regimen that should be used after this study should be the reduced-dose regimen and this has been demonstrated with apixaban," Mahé said at an ACC press conference. After cancer-related ...

Failure to make findings of fact adds twist to battle over Eliquis in Ireland ...

BMS is preparing for the loss of patent protection on some of its top-selling medicines, including cancer immunotherapy Opdivo (nivolumab) and anticoagulant Eliquis (apixaban), adding to the ...

"In these OAC-naive patients, asundexian was associated with a slight increase in stroke rates but demonstrated a lower risk ...